DGAP-News: Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals' LNA-modified ASOs to effectively block important immunosuppressive pathway

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Scientific publication